Industry News

AstraZeneca to open new $300 million manufacturing facility in Maryland

Feb. 7, 2024

The plant will focus on the manufacturing of CAR-T cell therapies to enable cancer clinical trials.

AstraZeneca has announced plans to open a new manufacturing facility in Rockville, Maryland. The biopharmaceutical company will invest $300 million into the project, generating 150 new jobs in the process. Operations at the new 84,000 square-foot facility are expected to begin in 2026. According to the company, the plant will focus on the manufacturing of CAR-T cell therapies to enable cancer clinical trials. The Maryland Department of Commerce is in the process of approving a $500,000 conditional loan through the Advantage Maryland program, while Montgomery County’s Economic Development Fund will contribute an additional $100,000 conditional grant.

In a recent quote, AstraZeneca Executive Vice President of Global Operations & IT and Chief Sustainability Officer Pam Cheng said, “We are incredibly excited that more than 150 new highly skilled jobs are being created to bring our scientific work and therapies to clinical trials which could transform the lives of patients around the world. This new $300 million investment will accelerate our ambition to make next-generation cell therapy a reality, ensuring that we are ready to scale and meet the demands of patients.”

Investing in American Manufacturing - 2024

This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.

About the Author

Alexis Gajewski | Senior Content Strategist

Alexis Gajewski has over 15 years of experience in the maintenance, reliability, operations, and manufacturing space. She joined Plant Services in 2008 and works to bring readers the news, insight, and information they need to make the right decisions for their plants. Alexis also authors “The Lighter Side of Manufacturing,” a blog that highlights the fun and innovative advances in the industrial sector.